Dr. Daphna Y. Gelblum, MD
- Medicare services, 2024
- 3,924
- Medicare patients, 2024
- 623
- Part D claims, 2024
- 446
- Publications
- 112
- Clinical trials
- 2
- Practice address
- 1275 York Avenue, New York, NY 10065
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Gelblum's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Daphna Y. Gelblum is a radiation oncologist in New York, New York
Dr. Gelblum practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.
Dr. Gelblum's NPI, 1215917604, was assigned on January 20, 2006. Dr. Gelblum graduated from University of Pittsburgh School of Medicine in 1994. Dr. Gelblum holds New York license 199763.
- NPI
- 1215917604NPI Registry (opens in a new tab)
- Medicare PAC ID
- 9234200494
- NPI enumeration date
- January 20, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 58
- Medical school graduation
- 1994
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Daphna Y. Gelblum practices at Memorial Sloan Kettering Cancer Center in New York, New York
Dr. Gelblum's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.
- Memorial Sloan Kettering Cancer Center1275 York Avenue, New York, NY 10065
Source: Dmand AI Affiliation Data
Dr. Daphna Y. Gelblum is affiliated with 6 sites of care and 7 medical groups
Dr. Gelblum's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Monmouth. Dmand AI also links Dr. Gelblum to 6 more medical groups and 5 group practices and clinics, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Daphna Y. Gelblum's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gelblum practices, 6 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Memorial Sloan Kettering Cancer Center | Available with a free account |
| +5 more sites and 6 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Memorial Sloan Kettering Cancer Center and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Daphna Y. Gelblum is one of 385 radiation oncologists in New York
Radiation oncology is Dr. Gelblum's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Gelblum is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Gelblum's licenses on file in 4 states: New York, Florida, New Jersey and Connecticut.
Specialties and state licenses
- Radiation oncology, New YorkPrimary
- Florida license
- New Jersey license
- Connecticut license
Clinical focus
Dmand AI lists bone cancer radiation, head & neck cancer radiation, lung cancer radiation and uterine cancer radiation among the conditions Dr. Gelblum treats.
Radiation oncologists near Dr. Gelblum
Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Daphna Y. Gelblum billed Medicare for 3,924 services in 2024
CMS data shows 3,924 Medicare services from Dr. Gelblum across 17 procedure codes in 2024, for 623 Medicare patients. Medicare paid $285,112 for them.
Dr. Gelblum's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Other services
- 2023: 1,4012024: 1,73924%
- Imaging
- 2023: 1,5412024: 1,5923%
- Office and hospital visits
- 2023: 3832024: 44616%
- Surgery
- 2023: 882024: 14767%
Where Dr. Gelblum's Medicare services took place, 2024
- In an office3,88499%
- In a facility401%
Dr. Gelblum compared with the New York median for radiation oncologists, 2024
- Dr. Gelblum
- New York median
- Medicare services
- 3,924vs 1,0543.7 times
- Medicare patients
- 623vs 1603.9 times
- Part D claims
- 302vs 368.4 times
Medians across 368 radiation oncologists in New York with Dmand AI profiles that report each measure.
Dr. Gelblum's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Gelblum?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Gelblum and other radiation oncologists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Daphna Y. Gelblum treated 623 Medicare patients in 2024, average age 75
CMS counts 623 Medicare patients who saw Dr. Gelblum in 2024. The largest group is 65 to 74, with 301 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 10% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Gelblum's median patient age at 71, with 44% women.
Dr. Gelblum's Medicare patients by age, 2024
Dr. Gelblum's Medicare patients by sex, 2024
- Women29347%
- Men33053%
Chronic conditions among Dr. Gelblum's Medicare patients, 2024
- High cholesterol75%
- High blood pressure74%
- Cancer67%
- Arthritis41%
- Ischemic heart disease34%
- Anxiety31%
- Diabetes26%
- Mood disorders25%
Share of Medicare patients with each condition. A patient can have several.
Dr. Gelblum's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 71
Patient panel by sex, all payers
- Women44%
- Men55%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Daphna Y. Gelblum wrote 446 Medicare Part D claims in 2024
In 2024, Dr. Gelblum wrote 446 Medicare Part D claims for 140 patients. 86% of them were for generic drugs. CMS names the drug for 302 of them, across 15 drugs with 11 or more claims each, at $5,452 in total drug cost. In 2023, CMS named 312 claims across 15 drugs.
Dr. Gelblum's Part D claims by kind of drug, 2024
- Generic385 claims86%
- Brand-name26 claims6%
- Other35 claims8%
Dr. Gelblum's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Gelblum's Part D claims, 2024
- Opioids20%90 of 446 claims
- Antibiotics5%23 of 446 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 3122024: 3023%
Drugs named by CMS: 15 in 2024, 15 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Daphna Y. Gelblum scored 91 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Gelblum for performance year 2024, reported as part of a group. Dr. Gelblum accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gelblum as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Gelblum's MIPS scores, performance year 2024
- 91of 100Final score
- 93.7of 100Quality
- 40of 100Improvement Activities
- 72of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Daphna Y. Gelblum has 112 publications on record
Dmand AI links 112 papers to Dr. Gelblum, published from 2010 to 2025. 2023 was the busiest year, with 15. The most frequent topics are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and Chemoradiotherapy. Dr. Gelblum has published most often in Int J Radiat Oncol Biol Phys. Dr. Gelblum's most frequent co-authors are Abraham Jing-Ching Wu, MD, Andreas Rimner, MD and Narek Shaverdian, MD.
Dr. Gelblum's papers by year, 2016 to 2025
Topics Dr. Gelblum writes about most
- Lung Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Chemoradiotherapy
- Head and Neck Neoplasms
- Radiotherapy Dosage
- Radiotherapy, Intensity-Modulated
- Radiosurgery
- Oropharyngeal Neoplasms
Dr. Gelblum's most frequent co-authors
- Abraham Jing-Ching Wu, MD43 shared papers
- Andreas Rimner, MD39 shared papers
- Narek Shaverdian, MD33 shared papers
Recent publications by Dr. Gelblum
Int J Radiat Oncol Biol Phys
Radiother Oncol
See who Dr. Gelblum researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Gelblum works with, so you can find a warm path to the right radiation oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Daphna Y. Gelblum has worked on 2 clinical trials
Dmand AI links Dr. Gelblum to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung and Carcinoma, Bronchogenic.
Clinical trials with Dr. Gelblum by phase
- 1Phase 1: 1 trial
- 1Phase 2: 1 trial
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Gelblum's trials
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Bronchogenic
Investigators on the most trials with Dr. Gelblum
- Andrew M. Baschnagel1 shared trial
- Jennifer T. Eubanks, MD1 shared trial
- Shruti Jolly, MD1 shared trial
Recent clinical trials with Dr. Gelblum
Radiation Therapy to Relieve Symptoms in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) (opens in a new tab)
Study of Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy in Patients With Stage III Non-small Cell Lung Cancer (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Daphna Y. Gelblum received $1,085 in industry payments from 2017 to 2024
CMS Open Payments shows 8 general payments to Dr. Gelblum from 3 drug and device companies from 2017 to 2024. Travel and lodging make up the largest share, 87% of the total. Merck Sharp & Dohme Corporation paid the most, $1,048.
General payments to Dr. Gelblum by program year, 2017 to 2024
General payments to Dr. Gelblum by kind, 2017 to 2024
- Travel and lodging$94287%
- Food and beverage$13212%
- Education$111%
Companies that paid Dr. Gelblum the most, 2017 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Daphna Y. Gelblum graduated from University of Pittsburgh School of Medicine
Dr. Gelblum graduated from University of Pittsburgh School of Medicine in 1994. Dr. Gelblum is a member of ASTRO and ASCO.
- Medical school
- Board certified in radiation oncology
Source: Dmand AI Professional Profile Data
Dr. Daphna Y. Gelblum accepts plans from 14 insurance carriers
Dr. Gelblum is in network with 14 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.
- Aetna
- Elevance
- Excellus BlueCross BlueShield
- Blue Cross Blue Shield of Michigan
- United Healthcare
- Blue Cross Blue Shield of Massachusetts
- HCSC
- MVP Health Care
- +6 more carriersWith a free account
Plan types Dr. Gelblum accepts, by number of carriers
- Medicare9
- PPO9
- POS6
- EPO5
- HMO5
- Medicaid2
Source: Dmand AI Insurance Network Data
Sources for Dr. Daphna Y. Gelblum's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Daphna Y. Gelblum
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Daphna Y. Gelblum's NPI number?
Dr. Daphna Y. Gelblum's NPI number is 1215917604. It was assigned on January 20, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Daphna Y. Gelblum?
Dr. Daphna Y. Gelblum is a radiation oncologist in New York, New York. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).
Where does Dr. Daphna Y. Gelblum practice?
Dr. Gelblum practices at 1275 York Avenue, New York, NY 10065. Dr. Gelblum's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Gelblum to 6 medical groups and 5 group practices and clinics.
What is Dr. Daphna Y. Gelblum's medical license number?
Dr. Gelblum holds New York license 199763, one of the licenses on file in 4 states.
Which states has Dr. Daphna Y. Gelblum been licensed in?
Dmand AI has state licenses on file for Dr. Gelblum in New York (1995 to 2026), Florida (since 2023), New Jersey (2019 to 2027) and Connecticut (2017 to 2025).
Which hospitals is Dr. Daphna Y. Gelblum affiliated with?
Dr. Gelblum practices at Memorial Sloan Kettering Cancer Center in New York, New York.
What medical group is Dr. Daphna Y. Gelblum part of?
Dr. Gelblum is linked to Memorial Sloan Kettering Monmouth. Dmand AI links Dr. Gelblum to 6 more medical groups.
Does Dr. Daphna Y. Gelblum accept Medicare?
Yes. CMS data shows Dr. Gelblum billed Medicare for 3,924 services in 2024, and Dr. Gelblum accepts Medicare assignment.
Does Dr. Daphna Y. Gelblum offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Gelblum as offering telehealth services.
What is Dr. Daphna Y. Gelblum's MIPS score?
Dr. Gelblum's MIPS final score for performance year 2024 is 91 out of 100, reported as part of a group.
Show 10 more questionsShow fewer questions
How many Medicare patients does Dr. Daphna Y. Gelblum see?
CMS counts 623 Medicare patients who saw Dr. Gelblum in 2024, with an average age of 75.
Is Dr. Daphna Y. Gelblum board certified?
Yes. Dr. Gelblum is board certified in radiation oncology by the American Board of Radiology.
What services does Dr. Daphna Y. Gelblum bill to Medicare?
In 2024, Dr. Gelblum's most billed Medicare services were medicare service (G6002), radiation oncology (77300) and radiation oncology (77427).
Where did Dr. Daphna Y. Gelblum go to medical school?
Dr. Gelblum graduated from University of Pittsburgh School of Medicine in 1994.
What drugs does Dr. Daphna Y. Gelblum prescribe most?
In 2024 Medicare Part D data, Dr. Gelblum's most prescribed drugs by claims were Oxycodone HCl, Pentoxifylline and Omeprazole.
Has Dr. Daphna Y. Gelblum received payments from drug or device companies?
CMS Open Payments shows $1,085 in general payments to Dr. Gelblum from 3 companies from 2017 to 2024. The largest total came from Merck Sharp & Dohme Corporation.
How long has Dr. Daphna Y. Gelblum been practicing?
Dr. Gelblum graduated from medical school in 1994, 32 years ago.
Does Dr. Daphna Y. Gelblum do research?
Dmand AI links 112 publications to Dr. Gelblum, published from 2010 to 2025. Dr. Gelblum has worked on 2 clinical trials.
Who does Dr. Daphna Y. Gelblum publish with?
Dr. Gelblum's most frequent co-authors are Abraham Jing-Ching Wu, MD (43 shared papers), Andreas Rimner, MD (39 shared papers) and Narek Shaverdian, MD (33 shared papers).
What insurance does Dr. Daphna Y. Gelblum accept?
Dr. Gelblum is in network with 14 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.
Selling to radiation oncology practices?
See radiation oncologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card